Kimberly Kraig Thompson - 10 May 2021 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
10 May 2021
Net transactions value
$0
Form type
4
Filing time
11 May 2021, 16:30:16 UTC
Previous filing
07 May 2021
Next filing
12 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -32,308 -0.02% 204,539,994 10 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 32,308 shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on May 10, 2021 at a price of $0.15 per share.
F2 Includes 204,539,992 shares of common stock that are owned by Mr. Thompson and 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson.